Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent ImplantationCheol Whan Lee, Seung‐Jung Park, Seung‐Woon Rha et al.|Circulation|2013Cited by 281
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting StentsSeung‐Jung Park, Keun Lee, Duk‐Woo Park et al.|Survey of Anesthesiology|2011Cited by 95
Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery LesionsJong‐Young Lee, Seung‐Jung Park, Duk‐Woo Park et al.|Circulation Cardiovascular Interventions|2014Cited by 34
AS-149: Angiographic Outcomes of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents for Native Coronary Arteries: Angiographic Study of the ZEST TrialYoung‐Hak Kim, Hun Sik Park, Duk‐Woo Park et al.|The American Journal of Cardiology|2010Cited by 0
AS-157: Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents for Patients with Diabetes Mellitus in the ZEST Trial: A Subanalysis of a Randomized TrialJongsun Park, Hun Sik Park, Duk‐Woo Park et al.|The American Journal of Cardiology|2010Cited by 0